Table 1 Baseline characteristics based on pSMI tertiles
Variable | T1(pSMI ≤ 6.95; n=447) | T2(6.95< pSMI≤ 7.77; n=447) | T3 (pSMI> 7.77; n=446) | P value |
|---|---|---|---|---|
pSMI | 6.25 ± 0.47 | 7.4 ± 0.24 | 8.35 ± 0.51 | < 0.001 |
Age, years | 73.91 ± 8.3 | 69.29 ± 9.55 | 61.42 ± 11.28 | < 0.001 |
Female, n (%) | 325(72.70) | 54(12.10) | 8(1.80) | < 0.001 |
Body weight, kg | 54.22 ± 6.5 | 65.21 ± 5.34 | 76.63 ± 8.66 | < 0.001 |
BMI, kg/m2 | 22.52 ± 2.9 | 24.45 ± 2.63 | 26.79 ± 3.01 | < 0.001 |
Smoking, n (%) | 100(22.40) | 282(63.10) | 310(69.50) | < 0.001 |
Heart failure, n (%) | 23(5.10) | 18(4.00) | 17(3.80) | 0.575 |
Previous AMI, n (%) | 11(2.5) | 20(4.5) | 17(3.8) | 0.256 |
Previous PCI, n (%) | 34(7.60) | 46(10.30) | 41(9.2. 0) | 0.371 |
COPD, n (%) | 18(4.00) | 19(4.3.00) | 9(2.00) | 0.131 |
Hypertension, n (%) | 325(72.70) | 308(68.90) | 302(67.70) | 0.237 |
Diabetes mellitus, n (%) | 177(39.60) | 180(40.30) | 202(45.30) | 0.169 |
Atrial fibrillation, n (%) | 20(4.50) | 19(4.30) | 10(2.20) | 0.147 |
Previous Stroke, n(%) | 20(4.50) | 29(6.50) | 14(3.10) | 0.059 |
Laboratory data | Â | Â | Â | Â |
SBP, mmHg | 135.36 ± 22.39 | 133.35 ± 21.09 | 132.06 ± 20.00 | 0.064 |
Heart rate, bpm | 78.57 ± 15.69 | 77.15 ± 13.99 | 77.75 ± 13.38 | 0.056 |
cTnT, pg/ml | 21.95(9.41,278.23) | 32.66(11.38, 625.25) | 26.61(11.17, 502.25) | 0.029 |
BNP, pg/ml | 115.00(49.80, 318.10) | 104.00(39.10, 301.60) | 80.75(25.10, 219.38) | < 0.001 |
Scr, mg/dl | 0.78(0.65, 0.96) | 0.91(0.78, 1.09) | 0.92(0.81, 1.05) | < 0.001 |
Cystatin C, mg/L | 1.32 ± 0.62 | 1.35 ± 0.73 | 1.29 ± 0.90 | 0.414 |
Uric acid, umol/L | 364.96 ± 119.15 | 378.71 ± 123.99 | 421.34 ± 127.99 | < 0.001 |
FBG, mmol/L | 1.35 ± 0.42 | 1.39 ± 0.7 | 1.28 ± 0.86 | 0.414 |
HbA1c | 7.22 ± 1.55 | 7.22 ± 1.73 | 7.36 ± 1.69 | 0.620 |
TG, mmol/L | 2.05 ± 1.51 | 1.62 ± 0.92 | 2.22 ± 1.76 | < 0.001 |
TC, mmol/L | 4.83 ± 1.33 | 4.29 ± 1.32 | 4.39 ± 1.27 | < 0.001 |
HDL-C, mmol/L | 1.29 ± 0.36 | 1.13 ± 0.31 | 1.04 ± 0.25 | < 0.001 |
LDL-C, mmol/L) | 2.89 ± 0.94 | 2.61 ± 0.98 | 2.7 ± 0.96 | 0.037 |
Haemoglobin, g/dL | 12.58 ± 1.73 | 13.50 ± 1.84 | 14.12 ± 1.87 | < 0.001 |
LVEF | 55.92 ± 9.99 | 55.06 ± 9.89 | 53.66 ± 9.34 | 0.074 |
Clinical presentation, n (%) | Â | Â | Â | 0.055 |
CCS | 38(8.50) | 42(9.40) | 31(7.00) | Â |
UA | 231(51.70) | 203(45.40) | 212(47.50) | Â |
NSTEMI | 83(18.60) | 97(21.70) | 74(16.60) | Â |
STEMI | 95(21.30) | 105(23.50) | 129(28.90) | Â |
Treatment | Â | Â | Â | Â |
Aspirin, n (%) | 432(97.10) | 429(96.40) | 438(98.90) | 0.055 |
P2Y12 receptor inhibitor, n(%) | 440(98.70) | 435(97.50) | 441(99.10) | 0.153 |
Statins, n (%) | 440(98.40) | 434(97.10) | 434(97.30) | 0.370 |
β-blockers, n (%) | 298(66.70) | 297(66.40) | 315(70.60) | 0.321 |
ACEI/ARB, n (%) | 211(47.20) | 194(43.40) | 234(52.50) | 0.025 |
Diuretics, n (%) | 88(19.70) | 80(17.90) | 69(15.50) | 0.253 |
Insulin, n (%) | 49(1.10) | 50(11.20) | 41(9.20) | 0.566 |
MVD, n (%) | 309(69.10) | 300(67.10) | 277(62.10) | 0.074 |
LM, n (%) | 27(6.00) | 13(2.90) | 24(5.40) | 0.069 |
Thrombosis, n (%) | 6(5.70) | 9(9.00) | 16(1.50) | 0.071 |
Long lesion, n (%) | 75(68.20) | 71(66.40) | 75(65.20) | 0.894 |
CTO, n (%) | 25(23.60) | 17(16.80) | 27(24.80) | 0.329 |
Number of stents | 1.46 ± 0.82 | 1.47 ± 0.97 | 1.53 ± 0.93 | 0.695 |
Length of stents, mm | 38.1 ± 24.3 | 39.67 ± 29.93 | 40.58 ± 28.32 | 0.948 |